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Appendix 1. Telehealth in chronic disease (TECH) model  
 
 
  
Reproduced from Salisbury C, Thomas C, O’Cathain A, Rogers A, Pope C, Yardley L, et al. TElehealth in 
CHronic disease: mixed-methods study to develop the TECH conceptual model for intervention design and 
evaluation. BMJ Open 2015; 5:e006448. doi:10.1136/bmjopen-2014-006448 with permission from BMJ 
Publishing Group Ltd  
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Appendix 2 Use of the TECH model to design the Healthlines Service intervention for 
patients with depression  
Model element Strategies included in intervention 
Engagement 
Patient Provide a ‘Welcome Pack’. Emphasise that support with technology will be provided. 
 Healthlines advisors provide technical support e.g. with getting logged in to websites. 
 Promote the advantages to patients of using Healthlines, based on perceived advantages 
identified in qualitative research and other literature, and address perceived 
disadvantages. 
 Encourage sense of personal care through seeking to maximise continuity of care from 
named Healthlines advisor. 
 Regular positive reinforcement through monthly telephone calls from Healthlines advisor. 
 Encourage sense of partnership between patient, Healthlines Service and GP through 
frequent communication. 
Health professional All communications seek to reinforce the message that the Healthlines Service is 
supporting and delivered alongside primary care. 
 Regular communication with primary care. 
 Messages to primary care continually emphasise evidence-based nature of interventions 
and guidance. 
Promoting self-management 
Behaviour change 
techniques 
Telephone encounters support use of the Living Life to the Full cognitive behaviour 
course, with additional modules relating to alcohol, exercise, relapse prevention. 
Intervention is tailored to patient’s needs and goals.  
Self-monitoring  Depression: Patients using Living Life to the Full regularly monitor their progress with self-
assessment modules. 
Feedback Telephone encounter scripts provide positive reinforcement of progress. 
Provide patient information Healthlines advisor works with patients to identify goals and then emails them links to 
further resources available on the Internet which have been quality assessed (e.g. alcohol 
advice, patient forums).  
Promote self-efficacy Using motivational interviewing approach, identify motivating factors, encourage action 
plans and goal setting.  
Motivational interviewing  All Healthlines advisors undertake motivational interviewing training. 
Shared decision making  Provide information about advantages and disadvantages of treatments, encourage 
patients to discuss options with GP, share letters to GPs with patients. 
Personal support from 
health professionals  
As far as possible, provide continuity of care from one named Healthlines advisor rather 
than an anonymous ‘call-centre’ approach. 
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Peer support Patients are offered option to access Big White Wall, an online forum for patients with 
depression. 
Treatment optimisation 
Risk stratification  Assessment using PHQ-9 and advice about treatment in relation to severity. Also used to 
assess suicidal risk with use of a protocol for escalation and more detailed risk 
assessment for patients at significant risk 
Treatment intensification  Regular review of progess and intensification of treatment if no improvement 
Evidence-based guidelines 
and protocols  
Healthlines advisors’ scripts all based on careful review of national guidelines. Encourage 
compliance with guidelines by sending GPs a simple flow chart summary with each 
treatment recommendation. 
Regular review  Healthlines advisors telephone patients monthly, based on scripts which raise new topics 
each month and review progress against goals 
Promote medication 
adherence  
Monthly review of medication adherence, scripts use evidence based strategies to 
improve adherence, advice to GPs by email if patients are non-adherent 
Share recommendations 
with patients  
Patients are given online access to guidelines and treatment recommendations sent to 
GPs. 
Care co-ordination 
Multi-component 
interventions  
Intervention combines interactive patient web portal, self-monitoring, self-management 
behavioural strategies and telephone support from health advisor. 
Shared records  At onset, Healthlines receives information about patients from primary care records. All 
treatment recommendations shared with both primary care provider and patient.  
Communication between 
the telehealth provider and 
primary care  
Regular progress reports sent to patient’s GP.  
Regular monitoring of 
system performance  
Reporting module which allows monitoring of management program (e.g. of number of 
patients who have been telephoned, number actively participating in on line cognitive 
behaviour therapy).  
Support rather than 
duplicate primary care  
All communications with primary care providers and patients reiterate the message that 
Healthlines Service is designed to support GPs in their role of managing patients. All 
treatment recommendations are made to GPs and copied to patients.  
Partnership 
 All communications are shared between Healthlines Service, patient and GP.  
 GPs and service managers involved in designing the Healthlines intervention 
Context 
 The nature and intensity of the intervention is tailored to the nature and severity of the 
patient’s health condition.  
 Patients are only invited to participate if they are above a specified severity threshold. 
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 Recognising that patients in the NHS have an enduring relationship with their GP, which 
reinforces the importance of supporting rather than duplicating or undermining that role 
 Not all patients have access to reliable Internet connections, so this intervention is only 
likely to be relevant to a proportion of those in need. Provide technical support to help 
patients, for example, log in to web portal. In evaluation, it is important to describe the 
characteristics of patients who take part. 
Adapted by permission from BMJ Publishing Group Limited. Salisbury C, Thomas C, O’Cathain A, Rogers A, Pope C, 
Yardley L, et al. TElehealth in CHronic disease: mixed-methods study to develop the TECH conceptual model for 
intervention design and evaluation. BMJ Open 2015; 5:e006448. doi:10.1136/bmjopen-2014-006448 
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Appendix 3. Details of model for imputation of missing data 
 
Missing data were imputed using the multiple imputation by chained equation procedure, 
implemented using the ‘ice’ command in Stata (StataCorp, version 13.1). Missing data for both 
clinical outcomes and economic analysis variables were imputed within the same model. The 
imputation model followed recommended practice1 by including allocation, demographic variables 
and cost variables without missing data, alongside outcome, cost and utility variables with missing 
data. The imputation model included past history of depression and depression status measured by 
the CIS-R at baseline and data on the following variables at baseline and all subsequent follow-up 
time-points: PHQ-9 score, GAD-7 score and whether participants were currently being prescribed 
antidepressants.  
The imputation model was stratified by trial arm and the number of imputations was set to 60, 
which ensured that the number of imputations was greater than the proportion of missing data. 
Predictive mean matching was used to account for non-Gaussian distributions in variables, 
particularly in the cost and utility variables included in the imputation model. Passive imputation 
was performed for categorical outcome models that were functions of imputed variables, such as 
binary variables indicating PHQ-9 responders. Finally, analysis was performed on the imputed data 
set in a way that reflected the variation within and between the imputed datasets in accordance 
with ‘Rubin’s rules’.1 
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Appendix 4 Primary and sensitivity analyses of primary outcome 
 Usual care  
% (n/total) 
Intervention 
 % (n/total) 
Adjusted 
odds ratio 
95% 
confidence 
interval 
P-value 
Primary analysis       
PHQ-9 response to treatment 19% 
(50/270) 
27% 
(68/255) 
1·7 
 
1·1 to 2·5 0·019 
 
Sensitivity analyses     
1.PHQ-9 response to treatment: 
simple imputation (assuming 
missing binary outcome is non-
response) 
17% 
(50/302) 
22% 
(68/307) 
1·5 
  
1·0 to 2·2 0·063 
2. PHQ-9 response to treatment: 
multiple imputation 
19% 
(56/302) 
28% 
(86/307) 
1·7 
 
1·1 to 2·6 0·010 
 
3. PHQ-9 response to treatment: 
not including GP practice as a 
random effect 
19% 
(50/270) 
27% 
(68/255) 
1·7 
 
1·1 to 2·5 0·019 
 
4. PHQ-9 response to treatment: 
adjusted by days since 
randomisation to completion of the 
primary outcome 
19% 
(50/270) 
27% 
(68/255) 
1·7 
 
1·1 to 2·5 0·018 
 
5. PHQ-9 response to treatment: 
adjusted by days since 
randomisation to completion of the 
primary outcome and baseline 
outcomesa 
19% 
(50/270) 
27% 
(68/255) 
1·9 
 
1·2 to 3·0 0·005 
 
a Binary or categorical baseline outcomes: work (binary: no work/work), highest qualification (categorical: none, 
GCSE, A-level, Degree), accommodation (binary: do not own house/own house), CIS-R (categorical: mild, 
moderate, severe), antidepressant use (binary: not currently antidepressants/currently taking antidepressants). 
All analyses are adjusted by site (Bristol, Sheffield or Southampton) and baseline PHQ-9 (Patient Health 
Questionnaire) score. GP practice is included as a random effect unless otherwise specified. Analyses are further 
adjusted by other covariates if specified.  
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Appendix 5 Use of technologies for health purposes 
Use of technologies for 
health purposes at least 
every 2 weeksa 
Usual care %  
(n) 
Intervention % 
(n) 
Adjusted 
odds ratiob 
95% 
confidence 
interval 
P-value 
NHS Direct phone services      
4 months <1% (1/248) 4% (8/226)    
8 months 1% (3/231) 3% (6/213)    
12 months <1% (1/239) 2% (4/222) 4·0 0·4, 36·5 0·216 
Online searching      
4 months 19% (47/247) 26% (60/227)    
8 months 24% (55/231) 27% (57/213)    
12 months 22% (53/237) 23% (51/223) 1·0 0·6, 1·7 0·964 
Online forum or group      
4 months 6% (15/249) 10% (23/225)    
8 months 7% (16/231) 7% (15/212)    
12 months 8% (18/235) 4% (10/223) 0·5 0·2, 1·1 0·072 
a Scale dichotomised as 0 = used less than once a month, 1 = every 2 weeks or more.  
b All analyses are adjusted by site (Bristol, Sheffield or Southampton), baseline PHQ-9 score and baseline 
outcome. GP practice is included as a random effect. 
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Appendix 6 Secondary outcomes at 4, 8 and 12 months follow-up 
 
 Usual care Intervention 
 Unadjusted 
mean (SD) 
N Unadjusted 
mean (SD) 
N 
Generalised anxiety (GAD-7)2   
4 months 10·5 (5·9) 250 10·5 (5·7) 227 
8 months 10·2 (5·7) 230 9·1 (5·4) 212 
12 months 9·2 (5·8) 237 8·7 (5·5) 223 
Quality of life (EQ-5D-5L)   
4 months 0·534 (0·29) 233 0·559 (0·29) 220 
8 months 0·541 (0·30) 227 0·556 (0·28) 210 
12 months 0·564 (0·30) 227 0·569 (0·30) 219 
Satisfaction with treatment a,b  
4 months 3·2 (0·9) 196 3·5 (0·9) 207 
8 months 3·3 (0·9) 182 3·6 (0·9) 172 
12 months 3·3 (0·9) 184 3·7 (0·9) 193 
Difficulties with obtaining access to care a,b  
4 months 3·9 (2·0) 244 4·4 (1·9) 226 
8 months 4·2 (1·9) 224 4·5 (1·8) 206 
12 months 4·2 (1·9) 232 4·5 (1·9) 216 
Satisfaction with amount of support received a,b  
4 months 2·1 (0·9) 191 2·5 (0·9) 200 
8 months 2·2 (0·8) 170 2·5 (0·8) 170 
12 months 2·1 (0·9) 177 2·6 (0·8) 185 
Self-management skills and self- efficacy (heiQ)3  
Physical activity a     
4 months 2·4 (0·9) 250 2·4 (0·9) 228 
8 months 2·4 (0·9) 228 2·3 (0·9) 213 
12 months 2·4 (0·9) 235 2·5 (0·9) 221 
Self-monitoring and insight a  
4 months 2·8 (0·4) 249 2·9 (0·4) 229 
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8 months 2·8 (0·5) 231 2·9 (0·4) 212 
12 months 2·4 (0·9) 237 3·0 (0·5) 221 
Constructive attitudes and approaches a  
4 months 2·5 (0·6) 250 2·6 (0·6) 229 
8 months 2·5 (0·6) 232 2·6 (0·6) 231 
12 months 2·6 (0·6) 238 2·7 (0·6) 221 
Skill and technique acquisition a  
4 months 2·6 (0·5) 250 2·6 (0·5) 228 
8 months 2·6 (0·5) 232 2·7 (0·5) 212 
12 months 2·6 (0·5) 239 2·8 (0·5) 221 
Health services navigationa  
4 months 2·7 (0·6) 250 2·8 (0·6) 228 
8 months 2·8 (0·6) 232 2·9 (0·6) 212 
12 months 2·8 (0·6) 238 2·9 (0·6) 220 
Adherence to anti-depressant medication (Morisky)4 a  
4 months 3·2 (1·0) 204 3·2 (1·1) 192 
8 months 3·4 (0·9) 181 3·3 (1·0) 163 
12 months 3·4 (0·9) 179 3·2 (1·1) 173 
Health literacy (eHEALs)5 a  
4 months 3·6 (0·9) 243 3·7 (0·8) 225 
8 months 3·7 (0·9) 229 3·8 (0·8) 212 
12 months 3·7 (0·8) 235 3·9 (0·8) 220 
Care coordination (Haggerty)6  
Role clarity and co-ordination a  
4 months 2·7 (0·8) 193 2·7 (0·7) 194 
8 months 2·8 (0·6) 183 2·8 (0·6) 171 
12 months 2·8 (0·5) 174 2·8 (0·6) 181 
Evidence of a care plan a  
4 months 2·9 (2·1) 199 3·3 (2·1) 197 
8 months 3·0 (2·2) 185 3·3 (2·1) 165 
12 months 3·1 (2·2) 176 3·5 (2·4) 179 
Overall experience of organisation of healthcare a   
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4 months 2·9 (1·0) 251 3·1 (1·0) 227 
8 months 3·0 (1·0) 232 3·1 (1·1) 213 
12 months 3·1(1·0) 236 3·2 (1·0) 219 
Self-organisation of healthcare a  
4 months 2·9 (1·2) 239 3·1 (1·3) 215 
8 months 3·1 (1·2) 224 3·1 (1·1) 204 
12 months 3·2 (1·2) 230 3·1 (1·2) 210 
     
a Higher score is more positive (less access difficulties, greater satisfaction) 
b Based on scales generated prior to the main trial analysis using principal components analysis and 
incorporating questions taken from existing validated questionnaires or constructed for this research. 
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Appendix 7. Use of anti-depressants by trial arm 
 Usual care Intervention    
 % n/N % n/N Adjusted  
Odds ratio 
95% 
confidence 
interval 
P-
value 
Taking antidepressant at baselinea  90% 258/288 87% 251/289 Not applicable 
Taking anti-depressants at 12 
month follow-upa 
78% 174/224 81% 172/213 1·6 0·9 to 2·8 0·103 
Anti-depressants prescribed 
during the trialb 
90% 273/302 90% 277/307 1·0          
                                                                                               
                                                                                              
0·5 to 1·9 0·934   
Had one or more changes in anti-
depressant medication or doseb 
47% 141/302 49% 150/307 1·1          
                                                                                               
                                                                                              
 0·8 to 1·5 0·545        
a Based on patient questionnaires 
b Based on medical records 
All analyses are adjusted by site, baseline use of antidepressants and baseline PHQ-9 score. GP practices is included as 
a random effect. 
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Appendix 8 Adverse events  
Diagnostic category Intervention Usual care Total 
Cancer 3 5 8 
Cardiovascular 2 5 7 
Dermatology 1 0 1 
Eyes 2 0 2 
Gastrointestinal 3 2 5 
Mental health 7 4 11 
Musculoskeletal 9 8 17 
Neurology 3 2 5 
Respiratory 1 5 6 
Unclear 1 2 3 
Urology/renal 2 3 5 
    Total 34 36 70 
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Appendix 9 Meta –review methods 
We searched Medline, Embase/AMED, PsycInfo, Web of Science, DARE (Database of Abstracts of 
Reviews of Effects) and The Cochrane Library for the period 1 January 2005 to 31 March 2010 for 
systematic reviews of telehealth and long term conditions.  Our search terms included “meta-review 
or meta review”, “quantitative review or overview”, “systematic review or systematic overview”, 
“methodologic* review or methodologic* overview”, “review” “quantitative synthes*”, “clinical 
trial” “randomized or randomised controlled trial” “controlled trial” and “telemedicine”, ‘telehealth 
or tele-health”, “telenursing”, “telemonitoring”, “Ehealth or e-health”, “”telehomecare”, 
“telehealthcare”, “home healthcare”, “assisted homecare”. 
These were combined with terms relating to long term conditions. Our definition of long term  
conditions was guided by the NHS National Service Framework for LTCs7 and other healthcare 
guidance.8-10 The list of long-term conditions included in the meta-review are listed below. 
Long-term conditions included in the meta-review  
 Chronic illness or chronic disease 
 Asthma 
 Coronary heart disease (CHD) or heart failure or coronary heart failure 
 Cardiovascular disease (CVD) 
 Stroke and transient ischaemic attack (TIA) 
 Hypertension 
 Diabetes mellitus 
 Chronic obstructive pulmonary disease (COPD) 
 Epilepsy 
 Thyroid disease (hypo or hyper) 
 Cancer 
 Dementia 
 Depression (& anxiety) 
 Mental health, including schizophrenia/psychosis/paranoia/obsessive compulsive 
disorder/post-traumatic stress disorder/agoraphobia 
 Chronic kidney disease (CKD) 
 Atrial fibrillation 
 Obesity 
 Spinal cord injury 
 Multiple sclerosis 
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 Motor neurone disease 
 Parkinson’s disease 
 Learning disabilities 
 Arthritis 
 Skin disease 
 Hearing difficulty 
 Headaches and migraine 
 Visual problems 
 Chronic liver disease 
 Endocrine disorders (e.g. Addison’s disease, Cushing’s syndrome) 
 Bronchiectasis 
 Cardiomyopathy 
 Crohn’s disease/ulcerative colitis 
 Glaucoma 
 Haemophilia 
 Hyperlipidaemia 
 Systemic lupus erythematosus and other systemic autoimmune diseases 
 Smoking (in relation to specific long-term conditions) 
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